Inderal (Propranolol Hydrochloride)

Propranolol, a non‑selective beta‑blocker, is used to manage cardiovascular and neurologic conditions by reducing sympathetic activity.

• Hypertension: reduces blood pressure by lowering heart rate and cardiac output.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Cardiac arrhythmias: stabilizes abnormal heart rhythms and prevents episodes.
• Migraine prophylaxis: diminishes frequency and severity of migraine attacks.
• Essential tremor: lessens tremor amplitude in patients.
• Symptomatic hyperthyroidism: controls tachycardia and other adrenergic symptoms.

• Propranolol Hydrochloride acts as a non‑selective antagonist of β1 and β2 adrenergic receptors. By blocking these receptors it inhibits catecholamine‑induced stimulation of the heart, leading to decreased heart rate, contractility, and conduction velocity, as well as reduced renin release from the kidneys. The resulting overall fall in cardiac output and peripheral resistance lowers blood pressure and diminishes myocardial oxygen demand.

Propranolol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Fatigue: feeling of tiredness or reduced energy.
• Dizziness: light‑headedness, especially upon standing.
• Cold extremities: reduced blood flow to hands and feet.
• Gastrointestinal upset: nausea, stomach discomfort or diarrhea.

Serious or Rare Side Effects

• Bradycardia: abnormally slow heart rate that may require medical attention.
• Hypotension: significant drop in blood pressure leading to fainting.
• Bronchospasm: tightening of airway muscles, especially in patients with asthma.
• Heart failure exacerbation: worsening of existing heart failure symptoms.

When prescribing propranolol, clinicians should observe several precautionary measures to ensure patient safety.

• Assess cardiovascular status: evaluate heart rate, blood pressure, and cardiac function before initiation.
• Review respiratory conditions: avoid use in patients with uncontrolled asthma or severe chronic obstructive pulmonary disease.
• Monitor glucose control: beta‑blockers may mask hypoglycemia symptoms in diabetic patients.
• Adjust dosage in renal or hepatic impairment: consider reduced clearance in these populations.
• Avoid abrupt discontinuation: taper the dose to prevent rebound hypertension or tachycardia.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture.

Propranolol can interact with several medicines, altering its effectiveness or increasing risk of adverse effects.

Major Interactions (Avoid)

• Combined with other β‑blockers: additive bradycardia and hypotension.
• Concomitant use with calcium channel blockers (verapamil, diltiazem): risk of severe heart block and heart failure.
• Non‑selective β‑blockers plus insulin or oral hypoglycemics: may conceal hypoglycemia signs.
• Concurrent MAO inhibitors: can cause extreme hypertension.
• Use with clonidine: abrupt withdrawal may precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely)

• Interaction with antidepressants (SSRIs, SNRIs): may increase plasma propranolol levels.
• Antithyroid drugs (propylthiouracil): may enhance beta‑blockade effects.
• NSAIDs (ibuprofen, naproxen): may reduce antihypertensive efficacy.
• Antacids containing aluminum or magnesium: may decrease absorption of propranolol.
• Digoxin: may increase risk of bradyarrhythmias.